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Editorial
On-and off-pump coronary artery bypass
surgery. The heart surgeon should master both
techniques
Coronary artery bypass grafting (CABG) has reinforced
its importance in the treatment of coronary artery disease
(CAD) with the latest scientific evidence, proving to be the
most effective in improving patient outcomes when
compared to other therapies, such as drug or interventionist,
especially in high risk patients. However, controversy
remains as to the technique to be employed, particularly
with regard to employment or not of cardiopulmonary
bypass (CPB).
The OPCABG emerged as an alternative technique to
avoid the deleterious effects of CPB, which negatively affect
the outcome of MRI, notably the systemic inflammatory
response syndrome, which leads to complications, inducing
organ dysfunction, and the need for cannulation and aortic
clamping which increases the incidence of cerebrovascular
accident (CVA). With the increasing complexity of cases
referred for surgery, these complications can compromise
the expected result and the implicit benefit for patients,
especially those with higher morbidity and older.
However, OPCAB surgery has been questioned
regarding its efficacy and safety in comparison to the
conventional technique, especially with the outcomes
related to incomplete revascularization and quality of grafts.
In this issue of BJCVS, the findings of the study by
Cerqueira Neto et al. [1] [pg. 283] reinforce that the quality
of the anastomosis of the left internal thoracic artery (LITA)
to left anterior descending artery (LAD) is similar, with
fluxometric data showing no difference between them, either
performed with or without CPB. Unfortunately, there was
no comparison with the grafts to other areas of the heart,
what would allow additional information and verifying that
the results also apply. However, the anastomosis of the
LITA to LAD stands today as the only strategy in CABG
surgery that increases survival.
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The quality of anastomosis in off-pump surgery is
implicitly related to surgeon experience. While experienced
surgeons performing the technique reported the same
degree of patency of the techniques over 8 years of follow-
up [2,3] in assays in which less experienced surgeons
operated, the results were inferior and high intraoperative
conversion rates as described in the Rooby study [4].
Similarly, while more experienced surgeons tend to perform
more complete revascularization, other surgeons reported
low outcomes.
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Meta-analyzes that compared the two strategies have
shown similar results, with a tendency to favor survival
and other outcomes in OPCAB [5], although other studies
have shown negative results. The Rooby study
demonstrated worse prognosis with this technique and a
published meta-analysis suggested a higher mortality rate
with off-pump technique [6].
The most recent published meta-analysis examined 59
trials, comprising 8966 patients and showed that off-pump
surgery reduces the incidence of stroke by 30% compared
to the conventional technique, with no difference in the
outcomes of 30-day mortality and perioperative infarction,
which were not affected by age, gender and number of
grafts [7].
The concept of incomplete revascularization has been
changing and new knowledge brought have changed this
dogmatic and stereotyped plea, whose different settings
involved in controversies about results in the medium and
long term.
Although complete revascularization is considered
superior to incomplete revascularization, with better
survival and lower reintervention in the long term, it is not
yet clear whether this difference is a direct consequence of
incomplete revascularization or if this approach is merely a
marker of more severe coronary disease and complex with
more rapid progression. Currently, it is discussed if indeed
incomplete revascularization may negatively affect long-
term outcome or may be the optimal treatment strategy in
selected cases of high-risk patients, minimizing risk of
perioperative mortality and morbidity and possibly allowing
a safer revascularization.
Thus, the analysis of the follow-up of 5 years of MASS
III study comparing 308 patients undergone surgery with
and without CPB, showed that the number of grafts per
patient was higher in the on-pump group than in the off-
pump group (2.97 vs. 2 , 49, P <0.001), but no difference
between groups in long-term outcomes (death, myocardial
infarction, new revascularization or stroke). [8] In the BARI
trial, complete or incomplete revascularization had no impact
on results in 7 years follow-up of patients [9].
Likewise, data from three years of the SYNTAX trial
reported the incidence and predictors of incomplete
revascularization after percutaneous coronary intervention
(PCI) or CABG, while incomplete revascularization was
associated with adverse events after PCI, and compared to
MRI there was no difference between groups. The rate of
incomplete revascularization was 43% for PCI and 37% for
MRI, reinforcing that the incidence of incomplete
revascularization was higher in patients with more complex
coronary artery disease, as patients enrolled in SYNTAX,
reflecting our current practice [10].
In the study group of Leipzig, in a cohort of 8806 patients
undergoing CABG with multivessel disease in which
approximately 10% had incomplete revascularization
(within the circumflex artery and the right coronary artery,
but with all the LITA grafted to the LAD) there was no
difference in survival at 3 years follow-up compared to
those with complete revascularization. The incomplete
revascularization was five times more frequent in patients
with more complex coronary heart disease. The authors
conclude that, in the presence of LITA grafted to the LAD
and other arteries (circumflex and right coronary) of poor
quality, incomplete revascularization did not affect survival
in the short or long term and may be a good therapeutic
option and should be balanced with the risks [11].
The anatomical criteria (SYNTAX score) and ischemic
functional tests have been challenged in the estimation of
the risk profile in incomplete revascularization. The FAME
study randomized 1005 patients with multivessel CAD to
complete anatomic revascularization (PCI in vessels of
adequate size, with stenoses of 50% to 100%) against
physiological incomplete revascularization based on
fractional flow reserve <0.80. The anatomically incomplete
revascularization, but configuring a complete ischemic
revascularization resulted in a 34% lower relative risk of
death or myocardial infarction at one year [12].
The CORONARY study, the largest prospective
randomized trial performed so far comparing strategies for
CABG with and without CPB, reported the results of 30
days involving 4752 patients and showed no significant
difference in the primary composite endpoint (death,
myocardial infarction, stroke or renal failure requiring
dialysis) between the two techniques. The off-pump group
showed a lower incidence of acute renal failure, reducing
the duration of mechanical ventilation and the incidence of
reoperation for bleeding, and lower rates of blood
transfusions and decreased respiratory complications.
However, there were fewer grafts and increased risk of
repeated revascularization. Interestingly, for the composite
endpoint in this study, patients operated in South America
had statistically better with OPCAB than with CPB [13].
The DOORS study randomized 900 patients elderly (>
70 years) for CABG with and without CPB, including
surgeons with intermediate experience in off-pump surgery.
Results at 30 days showed no statistical difference between
the two techniques, the composite endpoint of death, MI
and stroke [14].
The guidelines for revascularization of the European
Society of Cardiology 2010 and the American societies
published in 2011 reinforce the indications for use of off-
pump CABG in selected patients and with greater severity.
They recommend OPCAB in patients with mild to moderate
chronic renal insufficiency, with calcified aorta and
consequent increased risk of intraoperative stroke (in this
case, the technique of no-touch aorta is specifically
recommended), after angioplasty without success and also
VI
in patients with coagulation disorders, where without using
CPB may benefit the patient [15,16].
Likewise, in 2011, the National Institute for Health and
Clinical Excellence (NICE) has issued a document update in
OPCAB surgery, which, after review of the published evidence,
which reinforces that the safety and effectiveness are adequate
to support its use, since the conditions for clinical use are
provided, patient consent and data audit. The NICE document
emphasizes that OPCAB may also be particularly useful in
patients with left ventricular dysfunction, advanced aortic
atherosclerosis and the elderly [17].
It should be emphasized that the property of off-pump
CABG in reducing stroke event is related to surgical
technique, which effectively only the no-touch technique
of the ascending aorta reduces the risk of neurological
damage. The multiple manipulations of the ascending aorta
required by conventional surgery promote atheromatous
embolization, providing the probable mechanism for the
increased risk of stroke. Depending on the particular
technique used in OPCAB, there is elimination of 2 or 3 of
these aortic manipulations maneuvers.
Most studies comparing CABG with and without CPB
used the partial clamping of the ascending aorta to the
construction of the proximal anastomoses of vein grafts,
eliminating the plausible protective power of OPCAB.
Additionally, current guidelines also recommend the
intraoperative measure of graft flow, which can be especially
useful in OPCAB in order to reduce the incidence of early
grafts occlusion.
In the economic aspect, off-pump surgery has shown
to reduce the cost of the procedure in our country, which
constitutes an additional advantage in a country like ours,
with serious constraints of health budget and with welfare
hospitals tending to become budgeted. The substudy of
MASS-III, comparing the costs of the two techniques
showed that in OPCAB, there was decreased operating
expenses and that the economy could increase the ability
to care for patients by 25% [18,19].
In short, the training, the experience of the surgical team
and the organizational aspect is fundamental in achieving
results on the MRI, but more sharply in OPCAB technique.
Specific subgroups of patients may benefit from more than
one technique or the other, while a patient with chronic
renal failure may benefit most from OPCAB, another diabetic
patient with very ill arteries might need complete
revascularization with CPB using both ITAs. Both
techniques should therefore be seen as complementary and
not antagonistic, with property used to provide the best
outcome for our patients.
In this context, the emerging data suggests that an
additional beneficial to patients can be obtained if the
surgeon and staff dominate the two techniques and,
therefore, must now be trained in both.
REFERENCES
1. Cerqueira Neto FM, Guedes MAV, Soares LEF, Almeida GS,
Guimarães ARF, Barreto MA, et al. Fluxometria da artéria
torácica interna esquerda na revascularização da artéria
descendente anterior com e sem circulação extracorpórea. Rev
Bras Cir Cardiovasc. 2012;27(2):283-9
2. Puskas J, Williams WH, Mahoney EM, Huber PR, Block PC,
Duke PG, et al. Off-pump vs. conventional coronary artery
bypass grafting: early and 1-year graft patency, cost, and
quality-of-life outcomes: a randomized trial. JAMA.
2004;291(15):1841-9.
3. Angelini GD, Culliford L, Smith DK, Hamilton MC, Murphy
GJ, Ascione R, et al. Effects of on- and off-pump coronary
artery surgery on graft patency, survival, and health-related
quality of life: long-term follow-up of 2 randomized controlled
trials. J Thorac Cardiovasc Surg. 2009;137(2):295-303.
4. Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO,
Kozora E, et al. On-pump versus off-pump coronary-artery
bypass surgery. N Engl J Med. 2009;361(19):1827-37.
5. Kuss O, von Salviati B, Börgermann J. Off-pump versus on-
pump coronary artery bypass grafting: a systematic review
and meta-analysis of propensity score analyses. J Thorac
Cardiovasc Surg. 2010;140(4):829-35.
6. Møller CH, Penninga L, Wetterslev J, Steinbruchel DA, Gluud
C. Off-pump versus on-pump coronary artery bypass grafting
for ischaemic heart disease. Cochrane Database Syst Rev.
2012;3:CD007224.
7. Afilalo J, Rasti M, Ohayon SM, Shimony A, Eisenberg MJ.
Off-pump vs. on-pump coronary artery bypass surgery: an
updated meta-analysis and meta-regression of randomized
trials. Eur Heart J. 2012;33(10):1257-67.
8. Hueb W, Lopes NH, Pereira AC, Hueb AC, Soares PR, Favarato
D, et al. Five-year follow-up of a randomized comparison
between off-pump and on-pump stable multivessel coronary
artery bypass grafting. The MASS III Trial. Circulation.
2010;122(11 Suppl):S48-52.
9. Vander Salm TJ, Kip KE, Jones RH, Schaff HV, Shemin RJ, Aldea
GS, et al. What constitutes optimal surgical revascularization?
Answers from the Bypass Angioplasty Revascularization
Investigation (BARI). J Am Coll Cardiol. 2002;39(4):565-72.
10. Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes
DR, Ståhle E, et al. Comparison of coronary bypass surgery
with drug-eluting stenting for the treatment of left main and/or
three-vessel disease: 3-year follow-up of the SYNTAX trial.
Eur Heart J. 2011;32(17):2125-34.
11. Rastan AJ, Walther T, Falk V, Kempfert J, Merk D, Lehmann
S, et al. Does reasonable incomplete surgical revascularization
affect early or long-term survival in patients with multivessel
VII
coronary artery disease receiving left internal mammary artery
bypass to left anterior descending artery? Circulation.
2009;120(11 Suppl):S70-7.
12. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van't
Veer M; FAME Study Investigators, et al. Fractional flow
reserve versus angiography for guiding percutaneous coronary
intervention. N Engl J Med. 2009;360(3):213-24.
13. Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S,
Paolasso E; CORONARY Investigators, et al. Off-pump or
on-pump coronary-artery bypass grafting at 30 days. N Engl
J Med. 2012;366(16):1489-97.
14. Houlind K, Kjeldsen BJ, Madsen SN, Rasmussen BS, Holme
SJ, Nielsen PH, et al. On-pump versus off-pump coronary
artery bypass surgery in elderly patients: results from the
Danish on-pump versus off-pump randomization study.
Circulation. 2012;125(20):2431-9.
15. Task Force on Myocardial Revascularization of the European
Society of Cardiology (ESC) and the European Association
for Cardio-Thoracic Surgery (EACTS); European Association
for Percutaneous Cardiovascular Interventions (EAPCI), Kolh
P, Wijns W, Danchin N, Di Mario C, Falk V, Folliguet T, et al.
Guidelines on myocardial revascularization. Eur J Cardiothorac
Surg. 2010;38 (Suppl):S1-S52.
16. Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR,
Byrne JG; American College of Cardiology Foundation;
American Heart Association Task Force on Practice
Guidelines; American Association for Thoracic Surgery;
Society of Cardiovascular Anesthesiologists; Society of
Thoracic Surgeons, et al. 2011 ACCF/AHA Guideline for
Coronary Artery Bypass Graft Surgery. A report of the
American College of Cardiology Foundation/American Heart
Association Task Force on Practice Guidelines. Developed
in collaboration with the American Association for Thoracic
Surgery, Society of Cardiovascular Anesthesiologists, and
Society of Thoracic Surgeons. J Am Coll Cardiol.
2011;58(24):e123-210.
17. National Institute for Health and Clinical Excellence. Off-pump
coronary artery bypass grafting. Interventional procedure
guidance 377. Disponivel em: http://guidance.nice.org.uk/
IPG377.
18. Girardi P, Hueb W, Nogueira CR, Takiuti M, Nakano T, Garzillo
CL, et al. Custos comparativos entre a revascularização
miocárdica com e sem circulação extracorpórea. Arq Bras
Cardiol. 2008;91(6):369-76.
19. Gomes WJ, Braile DM. On-pump versus off-pump coronary
artery bypass surgery: the impact on costs of health care
systems. Arq Bras Cardiol. 2008;91(6):338-9.
VIII
